China Resources Double-Crane Pharmaceutical Co (SHSE:600062) Gross Margin % : 56.75% (As of Mar. 2024)

China Resources Double-Crane Pharmaceutical Co Gross Margin % Chart

China Resources Double-Crane Pharmaceutical Co Annual Data
	Trend	Dec14	Dec15	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23
Gross Margin %		Get a 7-Day Free Trial					63.43	63.01	55.77	55.45	55.24

China Resources Double-Crane Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Gross Margin %	Get a 7-Day Free Trial															55.65	56.61	53.47	55.06	56.75

Competitive Comparison of China Resources Double-Crane Pharmaceutical Co's Gross Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, China Resources Double-Crane Pharmaceutical Co's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

China Resources Double-Crane Pharmaceutical Co's Gross Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, China Resources Double-Crane Pharmaceutical Co's Gross Margin % distribution charts can be found below:

* The bar in red indicates where China Resources Double-Crane Pharmaceutical Co's Gross Margin % falls into.

China Resources Double-Crane Pharmaceutical Co Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

China Resources Double-Crane Pharmaceutical Co's Gross Margin for the fiscal year that ended in Dec. 2023 is calculated as

China Resources Double-Crane Pharmaceutical Co's Gross Margin for the quarter that ended in Mar. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.

China Resources Double-Crane Pharmaceutical Co  (SHSE:600062) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

China Resources Double-Crane Pharmaceutical Co had a gross margin of 56.75% for the quarter that ended in Mar. 2024 => Durable competitive advantage

Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.

China Resources Double-Crane Pharmaceutical Co Gross Margin % Related Terms

Thank you for viewing the detailed overview of China Resources Double-Crane Pharmaceutical Co's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

China Resources Double-Crane Pharmaceutical Co (SHSE:600062) Business Description